Oscar Health, Inc.
Oscar Health, Inc. (OSCR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
oscr · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Hold
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$30.00
Consensus
$20.80
-22.4% upside
Low
$16.00
Median: $20 · Last Close: $26.81
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$20.80
-22.4% upside
High Target
$30
11.9%
Low Target
$16
-40.3%
Current Price
$26.81
as of today
Based on analyst price targets, the OSCR stock price prediction for the next 12 months ranges from $16 to $30. The consensus OSCR price forecast of $20.80 implies -22.4% upside from the current price of $26.81.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.03 | ↑ 0.83% |
1-day model range: $26.77–$27.3. Peak: $27.3 (+0.83%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $32 | +17.6% |
| 2028 | $35 | +30.0% |
| 2029 | $37 | +38.2% |
| 2030 | $38 | +43.4% |
| 2031 | — | +46.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OSCR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-05-07 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2026-05-07 | UBS | Maintains | Neutral→Neutral |
| 2026-05-07 | Baird | Maintains | Neutral→Neutral |
| 2026-04-20 | Jefferies | Upgrade ↑ | Underperform→Hold |
| 2026-01-09 | UBS | Upgrade ↑ | Sell→Neutral |
| 2026-01-05 | Barclays | Upgrade ↑ | Underweight→Equal Weight |
| 2025-11-26 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2025-11-13 | Wells Fargo | Maintains | Underweight→Underweight |
| 2025-11-10 | Barclays | Maintains | Underweight→Underweight |
Wall Street analysts have recently issued updated ratings on Oscar Health, Inc. (OSCR) stock. Of the recent 66 rating actions, 8 were upgrades and 10 were downgrades. 11 analysts currently cover OSCR.
Analyst Recommendation Trends
OSCR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$18.5B
↓ 16.5% YoY
Revenue Next Year
$19.9B
↑ 7.4% YoY
EPS This Year
$0.90
EPS Next Year
$1.33
↑ 48.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast OSCR EPS of $0.90 for the current fiscal year, based on estimates from 6 analysts. The OSCR revenue forecast is $18.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The OSCR stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OSCR price target is $20.80 (-22.4% upside), with an analyst consensus of Hold.
The OSCR short-term stock prediction for tomorrow is $27.03 (+0.83%). The OSCR stock price prediction for 2027 estimates an average of $32. The OSCR stock prediction for 2030 projects a range of $34–$43.
Oscar Health, Inc. trades on NYSE under the ticker OSCR. The OSCR stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 18% of covering analysts.
Frequently asked questions
OSCR forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month OSCR price target is $20.80, with a high forecast of $30.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies -22.4% potential upside from the current price of $26.81.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.